Stocks · News reference
Alpha Buying: 4 Falling Knives Insiders Are Buying
There are dozens of reasons corporate executives sell shares. They may need money to pay taxes, buy a house, settle a divorce, diversify their wealth, or fund a new boat they will use three times before deciding they
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Truist Securities Maintains Hold on Amrize, Lowers Price Target to $35
Citigroup Maintains Buy on Amrize, Lowers Price Target to $50
Citigroup analyst Anthony Pettinari maintains Amrize (NYSE:AMRZ) with a Buy and lowers the price target from $58 to $50.
Barclays Initiates Coverage On Amrize with Equal-Weight Rating, Announces Price Target of $55
Barclays Initiates Coverage On Boston Scientific with Equal-Weight Rating, Announces Price Target of $48
Barclays analyst Christopher Pasquale initiates coverage on Boston Scientific (NYSE:BSX) with a Equal-Weight rating and announces Price Target of $48.
8-K filing — BOSTON SCIENTIFIC CORP (BSX)
Filed: 2026-10-07 AccNo: 0000885725-26-000064 Size: 292 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits